메뉴 건너뛰기
JAMA Neurology
Volumn 72, Issue 7, 2015, Pages 741-742
Advances in muscular dystrophies
Author keywords

[No Author keywords available]
Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ATALUREN; CORTICOSTEROID; DEFLAZACORT; DRISAPERSEN; DYSFERLIN; ETEPLIRSEN; FETAL PROTEIN DUX4; FETOPROTEIN; MYOSTATIN INHIBITOR; NITRIC OXIDE; PARVOVIRUS VECTOR; PHOSPHODIESTERASE INHIBITOR; PREDNISONE; PROTEIN INHIBITOR; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; UTROPHIN; DYSTROPHIN;
EID: 84937580747     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.4621     Document Type: Short Survey
Times cited : (24)
References (7)
  • 1
    • 84862704091 scopus 로고    scopus 로고
    • Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores
    • Boyden SE, Mahoney LJ, Kawahara G, et al. Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores. Neurogenetics. 2012;13(2):115-124.
    • (2012) Neurogenetics , vol.13 , Issue.2 , pp. 115-124
    • Boyden, S.E.1    Mahoney, L.J.2    Kawahara, G.3
  • 2
    • 84878390222 scopus 로고    scopus 로고
    • LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy
    • Flanigan KM, Ceco E, Lamar KM, et al United Dystrophinopathy Project. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol. 2013;73(4):481-488.
    • (2013) Ann Neurol , vol.73 , Issue.4 , pp. 481-488
    • United Dystrophinopathy Project1    Flanigan, K.M.2    Ceco, E.3    Lamar, K.M.4
  • 3
    • 84879551364 scopus 로고    scopus 로고
    • Corticosteroids in Duchenne muscular dystrophy: Major variations in practice
    • Griggs RC, Herr BE, Reha A, et al. Corticosteroids in Duchenne muscular dystrophy: major variations in practice. Muscle Nerve. 2013;48(1):27-31.
    • (2013) Muscle Nerve , vol.48 , Issue.1 , pp. 27-31
    • Griggs, R.C.1    Herr, B.E.2    Reha, A.3
  • 4
    • 84890805770 scopus 로고    scopus 로고
    • Eteplirsen for the treatment of Duchenne muscular dystrophy
    • Mendell JR, Rodino-Klapac LR, Sahenk Z, et al Eteplirsen Study Group. Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann Neurol. 2013;74(5):637-647.
    • (2013) Ann Neurol , vol.74 , Issue.5 , pp. 637-647
    • Mendell, J.R.1    Rodino-Klapac, L.R.2    Sahenk, Z.3
  • 5
    • 84907389831 scopus 로고    scopus 로고
    • Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy
    • Azakir BA, Erne B, Di Fulvio S, Stirnimann G, Sinnreich M. Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy. Sci Transl Med. 2014;6(250):250ra112.
    • (2014) Sci Transl Med , vol.6 , Issue.250
    • Azakir, B.A.1    Erne, B.2    Di Fulvio, S.3    Stirnimann, G.4    Sinnreich, M.5
  • 6
    • 84915829051 scopus 로고    scopus 로고
    • DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle
    • Yao Z, Snider L, Balog J, et al. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet. 2014;23(20):5342-5352.
    • (2014) Hum Mol Genet , vol.23 , Issue.20 , pp. 5342-5352
    • Yao, Z.1    Snider, L.2    Balog, J.3
  • 7
    • 84864439453 scopus 로고    scopus 로고
    • Targeting nuclear RNA for in vivo correction of myotonic dystrophy
    • Wheeler TM, Leger AJ, Pandey SK, et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 2012;488(7409):111-115.
    • (2012) Nature , vol.488 , Issue.7409 , pp. 111-115
    • Wheeler, T.M.1    Leger, A.J.2    Pandey, S.K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.